Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · October 10, 2022

Outcomes of Patients With Small and Node-Negative HER2+ Early Breast Cancer Receiving Adjuvant Chemotherapy and Anti-HER2 Therapy

British Journal of Cancer


Additional Info

Disclosure statements are available on the authors' profiles:

British Journal of Cancer
Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy-a sub-analysis of the ALTTO study
Br. J. Cancer 2022 Sep 01;[EPub Ahead of Print], G Nader-Marta, V Debien, D Eiger, Z Tsourti, R Caparica, M Kassapian, S Napoleone, S Hultsch, L Korde, Y Wang, S Chumsri, KI Pritchard, M Untch, M Bellet-Ezquerra, D Dornelles Rosa, A Moreno-Aspitia, M Piccart, U Dafni, E de Azambuja

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading